Compare Fastenal Company Common Stock (FAST) vs Nuvation Bio Inc. Class A Common Stock (NUVB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Fastenal Company Common Stock vs Nuvation Bio Inc. Class A Common Stock — how do they compare? Fastenal Company Common Stock trades at $50.59 (market cap $57.94B), while Nuvation Bio Inc. Class A Common Stock trades at $4.93 (market cap $1.74B). The key difference: Fastenal Company Common Stock is far larger — about 33.3× Nuvation Bio Inc. Class A Common Stock's market cap, and Fastenal Company Common Stock pays a 1.9% dividend while Nuvation Bio Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Fastenal Company Common Stock for 0 Days and Nuvation Bio Inc. Class A Common Stock for 0 Days on average.
| FAST | NUVB | |
|---|---|---|
Market Cap | $57.94B | $1.74B |
Volume | 6,764,575 | 9,289,619 |
Sector | Industrials | Health |
52-Week High | $52.38 | $9.54 |
52-Week Low | $39.15 | $3.41 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $58.17B | $1.33B |
Dividend Yield | 1.9% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Fastenal Company Common Stock
Fastenal distributes fasteners, tools, safety supplies, and other industrial products. It also provides inventory management and vending solutions for business customers.
Read more on FAST →About Nuvation Bio Inc. Class A Common Stock
Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →
